{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:52:35Z","timestamp":1771624355406,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV and inflammatory bowel disease (IBD) co-occur more frequently than would be expected by chance.<\/jats:p><jats:p><jats:bold>Case description:<\/jats:bold> A 16-year-old girl, who had been diagnosed with ulcerative colitis (UC) 2 years earlier at a general hospital, developed purpura, progressive abdominal pain with frequent bloody diarrhea and frontotemporal headache and swelling while on azathioprine and mesalamine maintenance therapy. Serology was positive for perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) without antiprotease- or myeloperoixidase antibodies. Endoscopy revealed active left-sided UC and atypical ulcerations in the ascending colon. Biopsies of these ulcerations and of affected skin revealed leukocytoclastic vasculitis. Initially this was interpreted as an extraintestinal manifestation of UC that would subside when remission was induced, consequently infliximab was started. Over the next 3 weeks she developed severe burning pain in her right lower leg that progressed to a foot drop with numbness and the purpura progressed to bullous lesions. The diagnosis was adjusted to ANCA-associated vasculitis with involvement of skin, bowel and peripheral nerves. Infliximab was discontinued and induction treatment with high-dose prednisolone and cyclophosphamide was given until remission of SVV and UC was achieved. Subsequently, infliximab induction and maintenance was re-introduced in combination with methotrexate. Remission has been maintained successfully for over 2 years now. The foot drop only partly resolved and necessitated the use of an orthosis.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Pediatric patients with IBD who present with purpuric skin lesions and abdominal pain should be evaluated for systemic involvement of SVV, which includes endoscopic evaluation of the gastrointestinal tract. We discuss a practical approach to the diagnosis, evaluation and management of systemic SVV with a focus on prompt recognition and early aggressive therapy to improve outcome.<\/jats:p>","DOI":"10.3389\/fped.2021.617312","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T13:09:35Z","timestamp":1612962575000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis"],"prefix":"10.3389","volume":"9","author":[{"given":"Marleen","family":"Bouhuys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wineke","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick F.","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i94","DOI":"10.1093\/ndt\/gfu393","article-title":"Vasculitis in children","volume":"30","author":"Eleftheriou","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/adc.85.5.427","article-title":"The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa","volume":"85","author":"Bakkaloglu","year":"2001","journal-title":"Arch Dis Child."},{"key":"B4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5152\/TurkPediatriArs.2015.2363","article-title":"Diagnostic approach and current treatment options in childhood vasculitis","volume":"50","author":"Barut","year":"2015","journal-title":"Turk Pediatri Ars."},{"key":"B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.pcl.2012.03.013","article-title":"Pediatric vasculitis","volume":"59","author":"Weiss","year":"2012","journal-title":"Pediatr Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fped.2018.00421","article-title":"Childhood vasculitis","volume":"6","author":"Schnabel","year":"2018","journal-title":"Front Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.7205\/MILMED-D-10-00409","article-title":"Leucocytoclastic vasculitis in severe ulcerative colitis","volume":"176","author":"Martin","year":"2011","journal-title":"Mil Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.62.8.785","article-title":"Leucocytoclastic vasculitis as onset symptom of ulcerative colitis","volume":"62","author":"Iannone","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/PAS.0000000000000135","article-title":"Coexistent pulmonary granulomatosis with polyangiitis (Wegener granulomatosis) and Crohn disease","volume":"38","author":"Vaszar","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrgastro.2016.179","article-title":"Gastrointestinal aspects of vasculitides","volume":"14","author":"Soowamber","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","article-title":"Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12887-020-02263-x","article-title":"Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Sch\u00f6nlein purpura patients: a retrospective analysis","volume":"20","author":"Paek","year":"2020","journal-title":"BMC Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s10067-017-3864-6","article-title":"Clinical significance of fecal calprotectin for the early diagnosis of abdominal type of Henoch-Schonlein purpura in children","volume":"37","author":"Teng","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/ard.2008.097758","article-title":"Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"68","author":"Merkel","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.tvir.2014.11.002","article-title":"Lewis JE. Diagnostic approach in patients with suspected vasculitis","volume":"17","author":"Sharma","year":"2014","journal-title":"Tech Vasc Interv Radiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/key322","article-title":"European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 international consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"m1070","DOI":"10.1136\/bmj.m1070","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter","year":"2020","journal-title":"BMJ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/art.40112","article-title":"Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Morishita","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"i104","DOI":"10.1093\/ndt\/gfv011","article-title":"Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study","volume":"30","author":"Sacri","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/gut.52.3.377","article-title":"Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease","volume":"52","author":"Stallmach","year":"2003","journal-title":"Gut."},{"key":"B27","first-page":"1058","article-title":"Intravenous pulse cyclophosphamide therapy in Crohn's disease and ulcerative colitis","volume":"53","author":"Barta","year":"2004","journal-title":"Gut."},{"key":"B28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5223\/pghn.2020.23.2.121","article-title":"F. Long-term efficacy of anti-tumor necrosis factor agents in pediatric luminal Crohn's disease: a systematic review of real-world evidence studies","volume":"23","author":"van Rheenen","year":"2020","journal-title":"Pediatr Gastroenterol Hepatol Nutr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi","year":"2012","journal-title":"Mayo Clin Proc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"Biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.617312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T13:09:40Z","timestamp":1612962580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.617312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":30,"alternative-id":["10.3389\/fped.2021.617312"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.617312","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"article-number":"617312"}}